cagrilintide semaglutide combination cagrisema phase 3 results 2025 2024 Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, The next frontier in metabolic

Food and Drug Administration PubMed PubMed No published multi year surveillance exists for adverse events, and current absence of large documented harm does not imply safety equivalence to approved therapeutics with rigorous post marketing data

doi:10.1038/s41467-021-20953-7 30

Managing side effects well is the difference between successful treatment and discontinuation

Serious Allergic Reactions: Rarely, vitamin B12 shots can cause anaphylactic shock, which can be life-threatening

Many weight loss clinics offer vitamin B12 shots to help patients lose weight more efficiently

Once they are significantly diminished, a prolonged deficiency can lead to substantial damage, especially to the nervous system